Physician profile
Thy B Nguyen
NPI 1659415123
$2,326.39
in general payments reported to CMS, 2019-2025
16 companies · $221 in 2025
The $221 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $477 · 2020: $59.97 · 2021: $335 · 2022: $552 · 2023: $400 · 2024: $282 · 2025: $221.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $902.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $902.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $476.89 | 2019 | |
| Novo Nordisk INC | $471.85 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $399.29 | 2021-2025 | |
| Abbott Laboratories | $383.55 | 2021-2022 | |
| Xeris Pharmaceuticals, INC. | $113.37 | 2023 | Gvoke Hypopen |
| Corcept Therapeutics | $101.08 | 2023 | Korlym |
| Pfizer INC. | $86.79 | 2023-2025 | |
| Amgen INC. | $78.76 | 2025 | |
| Optinose US, INC. | $41.47 | 2023 | |
| Lilly USA, LLC | $38.49 | 2023-2024 | Mounjaro, Zepbound, Trulicity |
| Exact Sciences Corporation | $33.97 | 2025 | Cologuard Collection Kit |
| Allergan, INC. | $27.23 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $21.64 | 2025 | Zoryve |
| Horizon Therapeutics Plc | $19.51 | 2022 | |
| Avion Pharmaceuticals | $17.20 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $15.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thy Nguyen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.